Navigation Links
China Information Technology, Inc. Announces Third Quarter 2011 Results
Date:11/9/2011

30,September 30,September 30,2011201020112010Revenue - Products$

13,042,469$

12,643,172$

32,162,844$

26,462,653Revenue - Software6,852,44729,474,26329,999,60567,059,131Revenue - System integration8,134,1101,347,98420,189,8277,617,390Revenue - Others433,545340,712946,8221,488,952TOTAL REVENUE28,462,57143,806,13183,299,098102,628,126Cost - Products sold10,315,50410,725,20324,910,65821,779,326Cost - Software sold2,534,25611,314,5858,921,14827,973,686Cost - System integration5,983,569621,31014,097,7623,667,840Cost - Others143,89459,440306,786205,922TOTAL COST18,977,22322,720,53848,236,35453,626,774GROSS PROFIT9,485,34821,085,59335,062,74449,001,352Administrative expenses(5,181,609)(5,449,209)(11,061,388)(10,840,741)Research and development expenses(1,106,500)(937,774)(2,990,237)(2,067,854)Selling expenses(1,831,845)(1,697,564)(5,270,739)(4,401,337)INCOME FROM OPERATIONS1,365,39413,001,04615,740,38031,691,420Subsidy income475,0266,521592,530438,201Other (loss) income, net(109,459)350,8741,481,792992,973Interest income119,86122,024254,80751,318Interest expense(943,947)(548,184)(2,420,600)(960,832)INCOME BEFORE INCOME TAXES906,87512,832,28115,648,90932,213,080Income tax expense(11,807)(2,361,593)(1,331,765)(5,696,285)NET INCOME895,06810,470,68814,317,14426,516,795Less: Net loss (income ) attributable to the non-controlling interest32,759139,080434,703(273,850)  NET INCOME ATTRIBUTABLE TO THE COMPANY$

927,827$10,609,768$14,751,847$26,242,945Weighted average number of sharesBasic53,801,84151,466,92752,994,32851,377,933Diluted53,801,84151,466,92752,994,32851,377,933Earnings per share - Basic and DilutedBasic - Net income attributable to the Company's common stockholders$

0.02$

0.21$

0.28$

0.51Diluted - Net income attributable to the Company's common stockholders$

0.02$

0.21$

0.28$

0.51CHINA INFORMATION TECHNOLOGY, INC.CONDENSED CONSOLIDATED STATEMENTS OF COMPR
'/>"/>

SOURCE China Information Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- Research and Markets ( ... "12th Annual Report and Survey of Biopharmaceutical ... offering. The 2015 12th Annual Report ... is the most recent study of biotherapeutic developers ... capacity and production. The report contains the industry,s ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... MYL ) shareholder vote regarding its planned unsolicited ... Mylan,s offer to Perrigo shareholders have always been, and ... reflection of the value available to Perrigo shareholders, and ... has allowed its shareholders to consider," said Joseph ...
Breaking Medicine Technology:12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Company, Limited (hereafter, Daiichi Sankyo), announced today that the ... (JAN: Edoxaban Tosilate Hydrate, INN:edoxaban) 15 mg and 30 ... Welfare in Japan. Edoxaban, which is being ... anticoagulant that specifically, reversibly and directly inhibits the enzyme, ...
... Ontario, April 21, 2011 Valeant Pharmaceuticals International, Inc. ... the following statement to shareholders of Cephalon, Inc. (NASDAQ: ... today, the Cephalon Board of Directors stated that it ... Company,s alternatives and options – and is focused on ...
Cached Medicine Technology:Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 2Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 3Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 4Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4
(Date:8/30/2015)... ... August 30, 2015 , ... Natural Rest contains a ... as sleep aids and calming remedies, which help to improve mood disorders and anxiety. ... great deal of research in the field of regenerative medicine conducted by Dr. Amit ...
(Date:8/29/2015)... ... 2015 , ... Rio Salado College President Chris Bustamante announced on ... of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the ... and impact through innovative technologies and strategies. , “I am very proud to be ...
(Date:8/29/2015)... ... August 29, 2015 , ... It ... and protection against dribbled urine and sweat. "In order to prevent these problems, ... The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/28/2015)... (PRWEB) , ... August 29, 2015 , ... Rio ... higher learning and the student experience as part of the EDUCAUSE - Next Generation ... Foundation . , This is the third Breakthrough Models Incubator hosted by ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4
... AMD Global Telemedicine Inc., Director of Clinical training, Diane Castelli appointed ... , ... North Chelmsford, MA (PRWEB) May 22, 2009 -- ... been elected by her colleagues to chair the American Telemedicine Association,s ...
... Associates, Inc., OMMA Healthcare, LLC and Medical Equipment ... supported by OMMA,s Middle East division, OMMA Projects-Middle ... Al Nidhal Construction. The Governorate of Baghdad selected ... Iraqi Hospital, Al Nahrein Hospital, previously Al Rasheed ...
... viruses with key toxicities removed, providing a new ... better vaccines for a broad range of viral ... of mRNA in different cell types, and this ... for cell-specific inactivation. Cancer Research UK scientists at ...
... Vega Tapped to Lead Health Care Improvement Firm,s ,Sales, Marketing Efforts ... ... today announced the addition of Al Vega as senior vice president and ... time of continued growth and will be responsible for driving sales and ...
... Delivery of PMTCTGENEVA, May 21 In a dramatic ... of the International Treatment Preparedness Coalition (ITPC) and AIDS-Free ... members of UNAIDS and WHO to present ITPC,s latest ... Failing Children: HIV, Vertical Transmission and Women,s Health, ...
... AFL ) announced today that it will make ... Conference. Chairman and Chief Executive Officer Daniel P. Amos ... a presentation on May 27, 2009, at 4:00 p.m. EDT. ... the company,s outlook for 2009 and its strategy for growth ...
Cached Medicine News:Health News:AMD Global Telemedicine Inc., Proud to Announce Diane Castelli, Chair of the American Telemedicine Association's (ATA) Telehealth Nursing Special Interest Group (SIG) 2Health News:An International Design Team has Been Selected for an Iraqi Hospital to Transform Healthcare in the Middle East 2Health News:MicroRNA regulation of tumor-killing viruses avoids unwanted viral pathology 2Health News:Press Ganey Names Chief Sales and Marketing Officer 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 3Health News:Aflac Incorporated to Present at the Sanford Bernstein 25th Annual Strategic Decisions Conference 2
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... System is a latex-free unisex system ... simple catheterization designed to reduce the ... It includes a 100% latex-free Mentor ... tear tab makes it easy to ...
... Self-Cath Closed System is a latex-free ... for safe, simple catheterization designed to ... infections. It includes a 100% ... new EasyOff tear tab makes it ...
... family of 100% latex-free ... variety of options for ... catheter is made of ... and has smooth fire ...
Medicine Products: